Optum Labs, the collaborative research and innovation center founded by Optum and Mayo Clinic, has announced the addition of seven new charter partners. These organizations, representing a broad cross-section of healthcare stakeholders, are American Medical Group Association; Boston University School of Public Health; Lehigh Valley Health Network; Pfizer, Inc.; Rensselaer Polytechnic Institute (RPI); Tufts Medical Center; and University of Minnesota School of Nursing.
“As the founding medical partner of Optum Labs, Mayo Clinic is excited to welcome the fresh insights and perspectives that new partners will bring to this collaboration,” says John Noseworthy, MD, president and CEO of Mayo Clinic. Adds Optum CEO Paul Bleicher, MD, PhD: “These additional charter partners will help Optum Labs accelerate the pace of innovation, paving the way for exciting new research initiatives.”
Optum Labs is a community of healthcare stakeholders dedicated to improving patient care by sharing information assets, technologies, knowledge, tools, and scientific expertise. Research is linked to the clinical environment through prototyping and testing in Optum and partners’ care settings.
More than 20 major research initiatives are currently underway, including studies that compare results from randomized clinical trials to analyses of observational data; research into geographic variation in care patterns; and analyses of the most effective approaches to consumer engagement and treatment. Results from Optum Labs research will be shared through scientific journals and presentations at professional meetings. Read about the 2013 launch of Optum Labs.
